Bicycle Therapeutics

NASDAQ: BCYC · Real-Time Price · USD
7.45
0.07 (0.95%)
At close: Aug 15, 2025, 3:59 PM
7.98
7.11%
After-hours: Aug 15, 2025, 07:33 PM EDT

Bicycle Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
879.52M 526.42M 339.15M 438.68M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
547K 547K n/a n/a
Other Long-Term Assets
10.53M 5.25M 8.46M 3.45M
Receivables
35.65M 24.04M 21.21M 11.91M
Inventory
n/a n/a n/a n/a
Other Current Assets
13.43M 11.41M 9.02M n/a
Total Current Assets
928.61M 561.87M 369.38M 458.56M
Property-Plant & Equipment
17.19M 27.68M 32.77M 17.79M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
28.26M 33.48M 41.23M 21.24M
Total Assets
956.87M 595.34M 410.61M 479.79M
Account Payables
15.79M 13.05M 6.47M 2.72M
Deferred Revenue
10.19M 24.98M 20.42M 19.27M
Short-Term Debt
5.5M 4.88M 3.13M 2.38M
Other Current Liabilities
30.24M 8.78M 10.27M 4.62M
Total Current Liabilities
67.23M 69.54M 53.34M 36.24M
Long-Term Debt
n/a 30.7M 30.32M 29.87M
Other Long-Term Liabilities
1.12M 4.58M 3.83M 3.28M
Total Long-Term Liabilities
96.58M 154.88M 86.48M 97.3M
Total Liabilities
163.81M 224.41M 139.83M 133.54M
Total Debt
9.49M 44.96M 44.33M 44.34M
Common Stock
890K 550K 387K 384K
Retained Earnings
-680.79M -511.76M -331.1M -218.38M
Comprehensive Income
119K -1.3M 387K -3.39M
Shareholders Equity
793.06M 370.93M 270.78M 346.25M
Total Investments
547K 547K n/a n/a